Physician profile
George Degheim
NPI 1710234158
$7,749.54
in general payments reported to CMS, 2019-2025
31 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,425 · 2020: $372 · 2021: $836 · 2022: $1,270 · 2023: $1,890 · 2024: $810 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,843 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,842.85 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,238.43 | 2019-2023 | Aveir, Diamondback Coronary, Cardiomems |
| Pfizer INC. | $586.70 | 2020-2024 | |
| Amgen INC. | $556.11 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $467.76 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $455.79 | 2019-2024 | |
| Shockwave Medical, INC | $375.59 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $346.09 | 2021-2024 | Micra, Mycarelink |
| Boston Scientific Corporation | $276.48 | 2022-2024 | Watchman Access System, Bodyguardian |
| Cardiovascular Systems INC. | $273.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $262.23 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $206.51 | 2019-2023 | Xarelto |
| Esperion Therapeutics, INC. | $195.14 | 2020-2024 | Nexletol |
| Heartflow, INC. | $193.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $177.20 | 2019-2021 | |
| Cvrx, INC. | $160.63 | 2024 | Barostim Neo System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $135.55 | 2024 | |
| Edwards Lifesciences Corporation | $124.99 | 2019 | |
| Abiomed | $124.35 | 2022-2024 | Impella |
| Medtronic Vascular, INC. | $115.22 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.41 | 2019-2023 | Jardiance |
| Chiesi USA, INC. | $76.00 | 2022-2024 | Kengreal |
| Kestra Medical Technology Services, INC. | $70.62 | 2023-2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $62.25 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $51.26 | 2019-2023 | Eliquis |
| Arbor Pharmaceuticals, INC. | $46.92 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $20.60 | 2024 | Onpattro |
| Genzyme Corporation | $18.88 | 2023 | |
| Bracco Diagnostics INC. | $15.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2021 | |
| Amarin Pharma, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Degheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.